Shanghai Shyndec Pharmaceutical Co., Ltd.
Status: Publicly traded
Direct answer
Shanghai Shyndec Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 600420.SS.
Shanghai Shyndec Pharmaceutical Co., Ltd., established in 1996 and headquartered in Shanghai, China, operates as a pharmaceutical enterprise. The company focuses on the global production of various drug formulations. Its primary therapeutic areas of specialization include anti-infectives, cardiovascular and cerebrovascular treatments, oncology, metabolic disorders, and endocrine system conditions.
Can you invest in Shanghai Shyndec Pharmaceutical Co., Ltd.?
Yes. Shanghai Shyndec Pharmaceutical Co., Ltd. is publicly traded on SHH under the ticker 600420.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Shanghai Shyndec Pharmaceutical Co., Ltd.
Detailed equity research is provided by MarketSnap.